Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Giant Bilateral Adrenal Myelolipomas in a Non-Compliant Patient with Congenital Adrenal Hyperplasia

T. Brutvan, O. Psenicka, J. Krizova, M. Kotasova, J. Jezkova

. 2024 ; 25 (-) : e943005. [pub] 20240407

Language English Country United States

Document type Case Reports, Journal Article

BACKGROUND 21-hydroxylase deficiency, an essential enzyme for glucocorticoid and mineralocorticoid synthesis, is the cause of congenital adrenal hyperplasia (CAH) in more than 95% of cases. It is an autosomal recessive disorder encoded by the CYP21A2 gene, categorized into classical forms, which encompass the salt-wasting (SW) and simple virilizing (SV) forms, as well as the nonclassical form (NC). The aim of medical treatment is to replace missing glucocorticoids and, if necessary, mineralocorticoids, while also reducing elevated adrenal androgens. CASE REPORT We present the case of a 42-year-old woman with CAH who discontinued therapy during adolescence and was admitted to hospital with fatigue, nausea, and severe abdominal pain. A CT scan showed an extreme enlargement of the adrenal glands. Laboratory tests revealed elevated levels of 17-hydroxyprogesterone and other adrenal androgens, along with normal plasma metanephrine levels. Decreased morning cortisol levels suggested partial adrenal insufficiency requiring glucocorticoid replacement therapy. Due to the development of several serious complications and clinical deterioration, the multidisciplinary team recommended bilateral removal of masses measuring 300×250×200 mm on the right side and 250×200×200 mm on the left side. Histological and immunochemical examination confirmed the presence of giant myelolipomas with adrenal cortex hyperplasia. CONCLUSIONS Adrenal tumors, particularly myelolipomas, have a higher prevalence in patients with CAH. Our case report provides further evidence of the suspected link between non-compliant CAH therapy and the development of myelolipomas, along with promotion of their pronounced growth.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014354
003      
CZ-PrNML
005      
20240905134224.0
007      
ta
008      
240725e20240407xxu f 000 0|eng||
009      
AR
024    7_
$a 10.12659/AJCR.943005 $2 doi
035    __
$a (PubMed)38582958
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brutvan, Tomas $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
245    10
$a Giant Bilateral Adrenal Myelolipomas in a Non-Compliant Patient with Congenital Adrenal Hyperplasia / $c T. Brutvan, O. Psenicka, J. Krizova, M. Kotasova, J. Jezkova
520    9_
$a BACKGROUND 21-hydroxylase deficiency, an essential enzyme for glucocorticoid and mineralocorticoid synthesis, is the cause of congenital adrenal hyperplasia (CAH) in more than 95% of cases. It is an autosomal recessive disorder encoded by the CYP21A2 gene, categorized into classical forms, which encompass the salt-wasting (SW) and simple virilizing (SV) forms, as well as the nonclassical form (NC). The aim of medical treatment is to replace missing glucocorticoids and, if necessary, mineralocorticoids, while also reducing elevated adrenal androgens. CASE REPORT We present the case of a 42-year-old woman with CAH who discontinued therapy during adolescence and was admitted to hospital with fatigue, nausea, and severe abdominal pain. A CT scan showed an extreme enlargement of the adrenal glands. Laboratory tests revealed elevated levels of 17-hydroxyprogesterone and other adrenal androgens, along with normal plasma metanephrine levels. Decreased morning cortisol levels suggested partial adrenal insufficiency requiring glucocorticoid replacement therapy. Due to the development of several serious complications and clinical deterioration, the multidisciplinary team recommended bilateral removal of masses measuring 300×250×200 mm on the right side and 250×200×200 mm on the left side. Histological and immunochemical examination confirmed the presence of giant myelolipomas with adrenal cortex hyperplasia. CONCLUSIONS Adrenal tumors, particularly myelolipomas, have a higher prevalence in patients with CAH. Our case report provides further evidence of the suspected link between non-compliant CAH therapy and the development of myelolipomas, along with promotion of their pronounced growth.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a nádory nadledvin $x komplikace $x diagnóza $7 D000310
650    _2
$a nadledviny $7 D000311
650    12
$a kongenitální adrenální hyperplazie $x komplikace $x diagnóza $x genetika $7 D000312
650    _2
$a glukokortikoidy $x terapeutické užití $7 D005938
650    12
$a lipom $7 D008067
650    12
$a myelolipom $x diagnóza $x chirurgie $x komplikace $7 D018209
650    _2
$a steroid-21-hydroxylasa $x genetika $7 D013255
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Psenicka, Otakar $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
700    1_
$a Krizova, Jarmila $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
700    1_
$a Kotasova, Marcela $u Institute of Clinical Biochemistry and Laboratory Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
700    1_
$a Jezkova, Jana $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
773    0_
$w MED00183037 $t The American journal of case reports $x 1941-5923 $g Roč. 25 (20240407), s. e943005
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38582958 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134218 $b ABA008
999    __
$a ok $b bmc $g 2143870 $s 1226220
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 25 $c - $d e943005 $e 20240407 $i 1941-5923 $m The American journal of case reports $n Am J Case Rep $x MED00183037
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...